ArticleInternational journal of clinical and experimental pathology2015

Biomarkers of erlotinib response in non-small cell lung cancer tumors that do not harbor the more common epidermal growth factor receptor mutations.

Blanca D López-Ayllón et al.PubMed ↗Full text ↗

No numbers read from the abstract.